NCT00798434 - A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. | Biotech Hunter

Enrollment

794

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Urinary Bladder, Overactive

Interventions

DRUG

Placebo

placebo administered orally in the morning or evening.

DRUG

Fesoterodine fumarate

Fesoterodine fumarate is an antimuscarinic drug recently approved by the European Medicines Evaluation Agency for treatment of symptoms of overactive bladder syndrome.

Trial Locations (60)

1090

Pfizer Investigational Site, Vienna

2060

Pfizer Investigational Site, Antwerp

2317

Pfizer Investigational Site, Hamar

2600

Pfizer Investigational Site, Glostrup Municipality

3103

Pfizer Investigational Site, Tønsberg

7006

Pfizer Investigational Site, Trondheim

8200

Pfizer Investigational Site, Aarhus N

8500

Pfizer Investigational Site, Kortrijk

10249

Pfizer Investigational Site, Berlin

14052

Pfizer Investigational Site, Berlin

20100

Pfizer Investigational Site, Turku

28905

Pfizer Investigational Site, Getafe

30625

Pfizer Investigational Site, Hanover

31096

Pfizer Investigational Site, Haifa

33521

Pfizer Investigational Site, Tampere

34098

Pfizer Investigational Site, Istanbul

34362

Pfizer Investigational Site, Haifa

35100

Pfizer Investigational Site, Izmir

45200

Pfizer Investigational Site, Kouvola

46009

Pfizer Investigational Site, Valencia

55200

Pfizer Investigational Site, Samsun

60435

Pfizer Investigational Site, Frankfurt

71100

Pfizer Investigational Site, Foggia

81927

Pfizer Investigational Site, München

90029

Pfizer Investigational Site, OYS

91031

Pfizer Investigational Site, Jerusalem

B-2650

Pfizer Investigational Site, Edegem

B-9000

Pfizer Investigational Site, Ghent

00290

Pfizer Investigational Site, Helsinki

04109

Pfizer Investigational Site, Leipzig

04019

Pfizer Investigational Site, Terracina, LT

NO-0257

Pfizer Investigational Site, Oslo

3000-075

Pfizer Investigational Site, Coimbra

1990-273

Pfizer Investigational Site, Lisbon

4050-011

Pfizer Investigational Site, Porto

4099-005

Pfizer Investigational Site, Porto

4200-319

Pfizer Investigational Site, Porto

851 01

Pfizer Investigational Site, Bratislava

851 05

Pfizer Investigational Site, Bratislava

924 22

Pfizer Investigational Site, Galanta

040 15

Pfizer Investigational Site, Kosice - Saca

040 11

Pfizer Investigational Site, Košice

08760

Pfizer Investigational Site, Martorell

08208

Pfizer Investigational Site, Sabadell

07500

Pfizer Investigational Site, Manacor

241 23

Pfizer Investigational Site, Eslöv

416 85

Pfizer Investigational Site, Gothenburg

211 20

Pfizer Investigational Site, Malmo

211 52

Pfizer Investigational Site, Malmo

601 82

Pfizer Investigational Site, Norrköping

141 86

Pfizer Investigational Site, Stockholm

CH-8501

Pfizer Investigational Site, Frauenfeld

06100

Pfizer Investigational Site, Ankara

TN39 4SP

Pfizer Investigational Site, Bexhill-on-Sea

E11 1NR

Pfizer Investigational Site, Leytonstone

HA1 3UJ

Pfizer Investigational Site, Harrow

NE7 7DN

Pfizer Investigational Site, High Heaton

B17 0AA

Pfizer Investigational Site, Birmingham

W2 1NY

Pfizer Investigational Site, London

WC1E 6AU

Pfizer Investigational Site, London